|
Match
|
Document |
Document Title |
|
|
US20090311231 |
PRODUCT AND PROCESS FOR LIQUEFACTION OF MUCUS OR SPUTUM
Disclosed are compositions and methods for decreasing the viscosity and/or cohesiveness of and/or increasing the liquefaction of excessively or abnormally viscous or cohesive mucus or sputum. The...
|
|
|
US20090254831 |
YAHRZEIT SYSTEM AND METHOD
A method of and system for providing an electronic Yahrzeit display corresponding to the current date including determining a current date, performing a search in a database storing a plurality of...
|
|
|
7582300 |
Modulation of gamma delta T cells to regulate airway hyperresponsiveness
Disclosed is a method for regulation of airway hyperresponsiveness by modulating the action of γδ T cells in a patient. Also disclosed are methods for identifying compounds that regulate airway...
|
|
|
US20090162427 |
VACCINES USING NUCLEIC ACID-LIPID COMPLEXES
This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune...
|
|
|
7534438 |
Product and process for liquefaction of mucus or sputum
Disclosed are compositions and methods for decreasing the viscosity and/or cohesiveness of and/or increasing the liquefaction of excessively or abnormally viscous or cohesive mucus or sputum. The...
|
|
|
US20090093401 |
CYSTATIN C AS AN ANTAGONIST OF TGF-BETA AND METHODS RELATED THERETO
Disclosed are Cystatin C (CysC) homologues, including CystC homologues that act as antagonists or inhibitors of transforming growth factor-β (TGF-β). Also disclosed are methods to identify CystC...
|
|
|
7498047 |
Methods for treatment of thiol-containing compound deficient conditions
Methods for therapy of cystic fibrosis and other conditions are provided. The methods comprise one or more agents capable of increasing thiol-containing compound transport via a transporter system...
|
|
|
7468048 |
Joint aspirate facilitating device
A joint aspirate-facilitating device is provided including a flexible main panel that is secured to the joint to be aspirated. An inflatable bladder is secured to the main panel and is placed in...
|
|
|
US20080306000 |
Three-Dimensional Structures of TALL-1 and its Cognate Receptors and Modified Proteins and Methods Related Thereto
Disclosed are TALL-1 and TALL-1 receptor protein homologues (agonists and antagonists) designed based on the three-dimensional structure of sTALL-1, eBCMA and eBAFF-R; agonist homologues of APRIL;...
|
|
|
US20080248025 |
Gamma Delta T Cells and Methods of Treatment of Interleukin-17 Related Conditions
This invention generally relates to methods to treat conditions and diseases associated with interleukin-17 (IL-17) production. The invention also relates to methods of inhibiting γδ T cells, and...
|
|
|
US20080242640 |
Surfactant Lipids, Compositions Thereof and Uses Thereof
The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an...
|
|
|
US20080207556 |
Product and Process for Inhibition of Biofilm Development
Disclosed are compositions and methods for the inhibition of biofilm formation or reduction of existing or developing biofilms in a patient. These methods also inhibit the aggregation of bacteria...
|
|
|
US20080199509 |
Methods and Compositions for the Disruption of Biofilms
The invention relates to methods of inhibiting biofilm formation or reducing biofilms in a subject or on a device or surface by administering a charged compound such as a polyamino acid to a...
|
|
|
7374934 |
Cell populations and methods of production thereof
The present invention relates to novel immortalized precursor cell populations derived from embryonic stem cell populations and methods to produce such cell populations. Also disclosed is an assay...
|
|
|
US20080086070 |
Joint Aspirate Facilitating Device
A joint aspirate-facilitating device is provided including a flexible main panel that is secured to the joint to be aspirated. An inflatable bladder is secured to the main panel and is placed in...
|
|
|
US20080085883 |
OXIDANT SCAVENGERS FOR TREATMENT OF DIABETES OR USE IN TRANSPLANTATION OR INDUCTION OF IMMUNE TOLERANCE
The present invention relates, in one embodiment, to a method of preventing or treating diabetes using low molecular weight antioxidants. In a further embodiment, the invention relates to a method...
|
|
|
US20080070256 |
Non-Human Animal Models for B-cell Non-Hodgkin's Lymphoma and Uses Thereof
Disclosed are non-human animal models, and preferably, rodent models, and more preferably, mouse models, of B-cell Non-Hodgkin's Lymphoma (NHL). In particular, the present invention provides animal...
|
|
|
US20080064103 |
Product and method for treatment of conditions associated with receptor-desensitization
Particular members of the multisubunit immune recognition receptor (MIRR) family of receptors, specifically, the B cell antigen receptor (BCR), the pre-B cell receptor (pre-BCR), the pro-B cell...
|
|
|
US20080063629 |
METHOD FOR PRODUCTION OF NEUTROPHILS AND USES THEREFOR
An in vitro method for the differentiation of functionally mature neutrophils from stem cells is disclosed. Also disclosed are methods of producing genetically modified neutrophils in vitro and...
|
|
|
US20080031865 |
PRODUCT AND PROCESS FOR LIQUEFACTION OF MUCUS OR SPUTUM
|
|
|
US20070269426 |
Use of Soluble Gammadelta Cell Receptors for Regulating T Cell Function
Disclosed is a method of using soluble γδ T cell receptors to regulate a γδ T cell-mediated immune response in a mammal.
|
|
|
US20070243214 |
Genes and proteins associated with angiogenesis and uses thereof
Disclosed is a panel of biomarkers associated with angiogenesis, and the use of such biomarkers (genes, proteins, homologues and analogs thereof) to regulate angiogenesis. Methods for identifying...
|
|
|
7282477 |
Cystatin C as an antagonist of TGF-β and methods related thereto
Disclosed are Cystatin C (CysC) homologues, including CystC homologues that act as antagonists or inhibitors of transforming growth factor-β (TGF-β). Also disclosed are methods to identify CystC...
|
|
|
US20070179087 |
METHOD FOR TREATING INFLAMMATORY DISEASES USING HEAT SHOCK PROTEINS
This invention relates to a method to protect a mammal from a disease associated with an inflammatory response, and in particular, from an inflammatory disease characterized by eosinophilia, airway...
|
|
|
US20070149498 |
CANCER THERAPY
The present invention relates, in general, to cancer therapy, and, in particular, to a method of preventing or treating cancer using low molecular weight antioxidants (e.g., mimetics of superoxide...
|
|
|
US20070116691 |
Conditionally immortalized long-term stem cells and methods of making and using such cells
Disclosed are methods for conditionally immortalizing stem cells, including adult and embryonic stem cells, the cells produced by such methods, therapeutic and laboratory or research methods of...
|
|
|
7195766 |
Product and process for liquefaction of mucus or sputum
Disclosed are compositions and methods for decreasing the viscosity and/or cohesiveness of and/or increasing the liquefaction of excessively or abnormally viscous or cohesive mucus or sputum. The...
|
|
|
US20070048802 |
Method and kit for detection of autoimmune chronic urticaria
Disclosed is a rapid, non-invasive and highly specific and sensitive diagnostic assay for the identification of individuals with autoimmune chronic urticaria, which makes use of CD203c, and in some...
|
|
|
7169570 |
Method to identify regulators of cellular activation using Bcl10
Disclosed are methods for evaluating the activation of Bcl10 in a cell in response to a putative stimulus, as well as methods for evaluating or identifying a regulatory compound which regulates...
|
|
|
7160681 |
Method for regulating cell growth and assays related thereto
Disclosed are methods for assessing tumor cell growth in a patient for the diagnosis, monitoring and/or staging of tumor development. The method include the identification of reduced cdk6...
|
|
|
US20060223769 |
Vaccines using nucleic acid-lipid complexes
This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune...
|
|
|
7090865 |
Composition and method for treating autoimmune hemolytic anemia
Disclosed are a composition and method to treat or prevent antibody-induced anemia and particularly, autoimmune hemolytic anemia. The composition comprises a bisphosphonate and a pharmaceutically...
|
|
|
US20060135585 |
Compounds and methods for thiol-containing compound efflux and cancer treatment
Methods for therapy of cystic fibrosis and other conditions such as cancer are provided. The methods comprise one or more agents capable of increasing thiol-containing compound transport via a...
|
|
|
US20060111315 |
Method for inhibition of pathogenic microorganisms
Disclosed is a method for inhibiting the growth of a microorganism by high efficiency transfection of a human host cell with a nucleic acid encoding an antimicrobial agent, such that the host cell...
|
|
|
US20060094054 |
Fibulin-3 and uses thereof
Disclosed is a method and test kit to diagnose tumorigenicity or the presence of tumor cells in a patient by detecting the level of FBLN-3 expression or biological activity in the patient. Also...
|
|
|
US20060074062 |
Substituted porphyrins
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby...
|
|
|
US20060058245 |
Methods for treatment of thiol-containing compound deficient conditions
Methods for therapy of cystic fibrosis and other conditions are provided. The methods comprise one or more agents capable of increasing thiol-containing compound transport via a transporter system...
|
|
|
US20060030539 |
Product and process for inhibition of biofilm development
Disclosed are compositions and methods for the inhibition of biofilm formation or reduction of existing or developing biofilms in a patient. These methods also inhibit the aggregation of bacteria...
|
|
|
6974677 |
Human MEKK proteins, corresponding nucleic acid molecules, and uses therefor
Isolated nucleic acid molecules encoding human MEKK proteins, and isolated MEKK proteins, are provided. The invention further provides antisense nucleic acid molecules, recombinant expression...
|
|
|
US20050260198 |
Inhibition of factor B, the alternative complement pathway and methods related thereto
Disclosed are novel inhibitors of the alternative complement pathway and particularly, novel anti-factor B antibodies. Also disclosed is the use of such inhibitors to reduce or prevent airway...
|
|
|
US20050260140 |
Mucolytic and anti-elastase compounds and methods of use thereof
Disclosed are compositions and methods for decreasing the viscosity and/or cohesiveness of and/or increasing the liquefaction of excessively or abnormally viscous or cohesive mucus or sputum. Also...
|
|
|
6951733 |
Method for testing drug susceptibility of Mycobacterium tuberculosis
A novel agar medium for the isolation, sub-cultivation, and indirect or direct drug-susceptibility testing of Mycobacterium tuberculosis is disclosed. Also disclosed are methods of isolating and...
|
|
|
6916799 |
Substituted porphyrins
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby...
|
|
|
6875749 |
Methods of facilitating vascular growth
A method of facilitating vascular growth in a subject in need of such treatment comprises inhibiting EMAP II activity in the subject by an amount effective to stimulate vascular growth in the...
|
|
|
US20050048055 |
Use of CD40 engagement to alter T cell receptor usage
The invention relates to methods for altering and enhancing the immune response toward an antigen. More specifically, the present invention relates to methods of using CD40 engagement on T cells to...
|
|
|
US20050008627 |
Modulation of gamma delta T cells to regulate airway hyperresponsiveness
Disclosed is a method for regulation of airway hyperresponsiveness by modulating the action of γδ T cells in a patient. Also disclosed are methods for identifying compounds that regulate airway...
|
|
|
US20040181037 |
Phosphatidyl serine receptors and uses thereof
Disclosed are phosphatidylserine (PS) receptors, including PS receptors from human, mouse, Drosophila melanogaster and Caenorhabditis elegans . Also disclosed are homologues of such receptors,...
|
|
|
US20040097454 |
Method for modulation of cell phenotype
Described is a method for modulating the phenotype of a cell, and particularly, of a target cell in a patient who has or is at risk of developing a disease or condition in which is associated with...
|
|
|
6737398 |
Modulation of &ggr &dgr T cells to regulate airway hyperresponsiveness
Disclosed is a method for regulation of airway hyperresponsiveness by modulating the action of γδ T cells in a patient. Also disclosed are methods for identifying compounds hyperresponsiveness by...
|
|
|
US20040039211 |
Tetrapyrroles
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby...
|